Early-Stage drug safety trial halted in healthy volunteers
Knowledge-focused
Terminated
This early-stage study aimed to check the safety and tolerability of an experimental drug called iCP-NI in healthy adults aged 18 to 55. Participants received either the drug or a placebo through an IV. The study was terminated early, so results are limited.
Phase: PHASE1 • Sponsor: Cellivery Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:08 UTC